Inflammatory events during murine squamous cell carcinoma development

[1]  C. R. Sipert,et al.  Salivary immunity in elderly individuals presented with Candida-related denture stomatitis. , 2012, Gerodontology.

[2]  T. Mcclanahan,et al.  IL-10 elicits IFNγ-dependent tumor immune surveillance. , 2011, Cancer cell.

[3]  M. Smyth,et al.  Stable IL-10: a new therapeutic that promotes tumor immunity. , 2011, Cancer cell.

[4]  G. MacLennan,et al.  IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients. , 2011, International journal of clinical and experimental pathology.

[5]  John S. Condeelis,et al.  Chemotaxis in cancer , 2011, Nature Reviews Cancer.

[6]  E. Jimi,et al.  The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma. , 2011, Oral diseases.

[7]  R. Franco,et al.  Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis. , 2011, Mutation research.

[8]  W. Schiemann,et al.  Transforming growth factor-β and the hallmarks of cancer. , 2011, Cellular signalling.

[9]  E John Wherry,et al.  T cell exhaustion , 2011 .

[10]  Guobin Wang,et al.  Th17 cells in cancer: help or hindrance? , 2011, Carcinogenesis.

[11]  K. Lee,et al.  Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. , 2011, Anticancer research.

[12]  J. Bromberg,et al.  Environment, inflammation, and cancer. , 2011, Current opinion in genetics & development.

[13]  Peter C Dedon,et al.  Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates , 2010, International journal of cancer.

[14]  D. Mika,et al.  Myeloperoxidase: the yin and yang in tumour progression. , 2011, Journal of experimental therapeutics & oncology.

[15]  E. Frei,et al.  Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency. , 2011, Biochimica et biophysica acta.

[16]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[17]  M. Horwitz,et al.  Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.

[18]  A. Storey,et al.  Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. , 2010, Carcinogenesis.

[19]  A. Georgakilas,et al.  The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. , 2010, Chemico-biological interactions.

[20]  B. Yan,et al.  Tumor Cell-Released TLR4 Ligands Stimulate Gr-1+CD11b+F4/80+ Cells to Induce Apoptosis of Activated T Cells , 2010, The Journal of Immunology.

[21]  A. Glick,et al.  TGFbeta1-induced inflammation in premalignant epidermal squamous lesions requires IL-17. , 2010, The Journal of investigative dermatology.

[22]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[23]  Ji-Yeob Choi,et al.  Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Hashida,et al.  Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. , 2009, Advanced drug delivery reviews.

[25]  W. Westra,et al.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. , 2009, Annual review of pathology.

[26]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[27]  W. Liles,et al.  The phagocytes: neutrophils and monocytes. , 2008, Blood.

[28]  M. Nishikawa.  Reactive oxygen species in tumor metastasis. , 2008, Cancer letters.

[29]  A. Georgakilas,et al.  Oxidative stress, DNA methylation and carcinogenesis. , 2008, Cancer letters.

[30]  M. Karin,et al.  The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. , 2008, Trends in molecular medicine.

[31]  F. Ciardiello,et al.  Chronic inflammation and oxidative stress in human carcinogenesis , 2007, International journal of cancer.

[32]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[33]  T. Fukutomi,et al.  Neutrophil elastase and cancer. , 2006, Surgical oncology.

[34]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[35]  B. Wollenberg,et al.  Role of cytokines in head and neck squamous cell carcinoma , 2006, Expert review of anticancer therapy.

[36]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[37]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[38]  S. Klebanoff.  Myeloperoxidase: friend and foe , 2005, Journal of leukocyte biology.

[39]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[40]  G. Trinchieri,et al.  Interleukin‐10 in viral diseases and cancer: exiting the labyrinth? , 2004, Immunological reviews.

[41]  A. Angelini,et al.  Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. , 2004, Archives of dermatology.

[42]  J. D. De Larco,et al.  The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8 , 2004, Clinical Cancer Research.

[43]  Zhifu Sun,et al.  Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. , 2004, The Lancet. Oncology.

[44]  D. Longo,et al.  Ammonium Trichloro(dioxoethylene-o,o′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop , 2004, Cancer Research.

[45]  J. Berzofsky,et al.  Role of IL-13 in regulation of anti-tumor immunity and tumor growth , 2004, Cancer Immunology, Immunotherapy.

[46]  L. Sibley,et al.  A novel population of Gr‐1+‐activated macrophages induced during acute toxoplasmosis , 2003, Journal of leukocyte biology.

[47]  Tomohiro Sawa,et al.  Chemical basis of inflammation-induced carcinogenesis. , 2003, Archives of biochemistry and biophysics.

[48]  Y. Saga,et al.  Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. , 2003, Cancer research.

[49]  K. Asadullah,et al.  Interleukin-10 Therapy—Review of a New Approach , 2003, Pharmacological Reviews.

[50]  C. Harris,et al.  Radical causes of cancer , 2003, Nature Reviews Cancer.

[51]  M. Lotze,et al.  Interleukin-17 promotes angiogenesis and tumor growth. , 2003, Blood.

[52]  F. Marks,et al.  Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  B. Bonavida,et al.  Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. , 2001, Cancer research.

[54]  G. Halliday,et al.  Infiltration by inflammatory cells required for solar-simulated ultraviolet radiation enhancement of skin tumor growth , 2001, Cancer Immunology, Immunotherapy.

[55]  B. Bonavida,et al.  Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  H. Granger,et al.  Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. , 2000, Blood.

[57]  C. Meisel,et al.  Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene. , 2000, Cancer research.

[58]  M. Bar‐eli,et al.  Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[59]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[60]  S J London,et al.  Myeloperoxidase genetic polymorphism and lung cancer risk. , 1997, Cancer research.

[61]  R. Ruggiero,et al.  A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours. , 1996, British Journal of Cancer.

[62]  A. Sober,et al.  Sun exposure and skin disease. , 1996, Annual review of medicine.

[63]  B. Halliwell,et al.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. , 1996, The Biochemical journal.

[64]  A. Pavone,et al.  12-O-tetradecanoylphorbol-13-acetate-mediated systemic co-promotion in the murine skin multistage carcinogenesis protocol. , 1993, Carcinogenesis.

[65]  L. Liotta,et al.  Tumor invasion and metastasis: an imbalance of positive and negative regulation. , 1991, Cancer research.

[66]  T. Hirano,et al.  [Interleukin-6 and its receptor]. , 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[67]  M. Nakajima,et al.  Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. , 1991, Seminars in cancer biology.

[68]  C. Wu,et al.  Cell associated elastase activities of rat mammary tumour cells. , 1990, Biochemistry international.

[69]  S. Weitzman,et al.  Inflammation and cancer: role of phagocyte-generated oxidants in , 2011 .

[70]  F. Lanza,et al.  Depressed neutrophil-mediated tumor cell cytotoxicity in subjects affected by hereditary myeloperoxidase deficiency and secondary neoplasia. , 1988, Haematologica.

[71]  P. Blumberg,et al.  Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. , 1988, Cancer research.

[72]  F. Lanza,et al.  Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms? , 1987, Journal of clinical & laboratory immunology.

[73]  A. Tauber.  Protein kinase C and the activation of the human neutrophil NADPH-oxidase. , 1987, Blood.

[74]  M. Zeydel,et al.  Collagenase and elastase production by mouse mammary adenocarcinoma primary cultures and cloned cells. , 1986, Cancer research.

[75]  Z. Werb,et al.  Mouse macrophage elastase. Purification and characterization as a metalloproteinase. , 1981, The Biochemical journal.

[76]  J. Travis,et al.  Human leukocyte granule elastase: rapid isolation and characterization. , 1976, Biochemistry.

[77]  J. Schultz,et al.  Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. , 1962, Archives of biochemistry and biophysics.